Unknown

Dataset Information

0

Patient Management Strategies and Long-Term Outcomes in Isolated Distal Deep-Vein Thrombosis versus Proximal Deep-Vein Thrombosis: Findings from XALIA.


ABSTRACT: Background ?Overall, 30 to 50% of lower-limb deep-vein thrombosis (DVT) cases are isolated distal DVT (IDDVT). The recurrent venous thromboembolism (VTE) risk is unclear, leaving uncertainty over optimal IDDVT treatment. We present data on patients with IDDVT and proximal DVT (PDVT) from the prospective, noninterventional XALIA study of rivaroxaban for acute and extended VTE treatment. Methods ?Patients aged ?18 years scheduled to receive ?3 months' anticoagulation with rivaroxaban or standard anticoagulation were eligible, with follow-up for ?12 months. We describe baseline characteristics, management strategies, and incidence proportions of VTE recurrence, major bleeding, and all-cause mortality in patients with IDDVT or PDVT, with or without distal vein involvement. Findings ?Overall, 1,004 patients with IDDVT and 3,098 with PDVT were enrolled; 641 (63.8%) and 1,683 (54.3%) received rivaroxaban, respectively. Patients with IDDVT were younger and had lower incidences of renal impairment, cancer, and unprovoked VTE than those with PDVT. On-treatment recurrence incidences for IDDVT versus PDVT were 1.0 versus 2.4% (adjusted hazard ratio [HR]: 0.56; 95% confidence interval [CI]: 0.29-1.08), and incidences posttreatment cessation were 1.1 versus 2.1% (adjusted HR: 0.65; 95% CI: 0.32-1.35), respectively. On-treatment major bleeding incidences were 0.9 versus 1.4% and mortality was 0.8 versus 2.2%, respectively. Median treatment duration in patients with IDDVT was shorter than in those with PDVT (102 vs. 192 days, respectively). Interpretation ?Patients with IDDVT had fewer comorbidities and were more frequently treated with rivaroxaban than those with PDVT. On-treatment and posttreatment recurrences were less frequent in patients with IDDVT. Trial registration number: ?NCT01619007.

SUBMITTER: Ageno W 

PROVIDER: S-EPMC6524913 | biostudies-literature | 2019 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Patient Management Strategies and Long-Term Outcomes in Isolated Distal Deep-Vein Thrombosis versus Proximal Deep-Vein Thrombosis: Findings from XALIA.

Ageno Walter W   Mantovani Lorenzo G LG   Haas Sylvia S   Kreutz Reinhold R   Monje Danja D   Schneider Jonas J   Bugge Jörg-Peter JP   Gebel Martin M   Turpie Alexander G G AGG  

TH open : companion journal to thrombosis and haemostasis 20190101 1


<b>Background</b>  Overall, 30 to 50% of lower-limb deep-vein thrombosis (DVT) cases are isolated distal DVT (IDDVT). The recurrent venous thromboembolism (VTE) risk is unclear, leaving uncertainty over optimal IDDVT treatment. We present data on patients with IDDVT and proximal DVT (PDVT) from the prospective, noninterventional XALIA study of rivaroxaban for acute and extended VTE treatment. <b>Methods</b>  Patients aged ≥18 years scheduled to receive ≥3 months' anticoagulation with rivaroxaban  ...[more]

Similar Datasets

| S-EPMC9246482 | biostudies-literature
| S-EPMC6738897 | biostudies-literature
| S-EPMC9472408 | biostudies-literature
| S-EPMC9682494 | biostudies-literature
| S-EPMC6524861 | biostudies-literature
| S-EPMC8094969 | biostudies-literature
| S-EPMC8030742 | biostudies-literature
| S-EPMC8174250 | biostudies-literature
| S-EPMC7590310 | biostudies-literature
| S-EPMC6788761 | biostudies-literature